Baseless and DDD, it appears that both of you would like to see the door smash DR on the bum as she leaves the company on her last day. I know why you have the sentiments you have shared but we should be mindful that these types of companies aren't that easy to run when they have been listed on the fickle, impatient ASX. That could be confirmation of a bad decision at the outset but I don't want to start on the lack of alternative funding in the Aus market for life science companies. The fact is, BNO, with DR at the helm, gave it a go. It didn't work out as well as we would have liked. Maybe there were errors made on the way. Maybe there was some hype that shouldn't have been there. But, I'd rather we didn't play the (wo)man and focus on the company's failings, the lessons that can be learned, the positives that have come from it, and the future for BNO, if anything in the long term. I hope we have all learned a lot along the way.
On another point, given your comment about the advisors driving Porsches etc DDD, are you driving a Kia like I am? GLTA
BNO Price at posting:
11.5¢ Sentiment: Hold Disclosure: Held